Hakan Özdoğu
About
Hakan Özdoğu is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Hakan Özdoğu has authored 96 papers receiving a total of 963 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Hematology, 42 papers in Genetics and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hakan Özdoğu's work include Hemoglobinopathies and Related Disorders (31 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Iron Metabolism and Disorders (15 papers). Hakan Özdoğu is often cited by papers focused on Hemoglobinopathies and Related Disorders (31 papers), Hematopoietic Stem Cell Transplantation (17 papers) and Iron Metabolism and Disorders (15 papers). Hakan Özdoğu collaborates with scholars based in Türkiye, France and Italy. Hakan Özdoğu's co-authors include Can Boğa, İlknur Kozanoğlu, Süheyl Asma, Mahmut Yeral, Feride İffet Şahin, Sema Karakuş, Çiğdem Gereklioğlu, Zerrin Yılmaz, Zafer Gülbaş and Filiz Koç and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Medicine.
In The Last Decade
Hakan Özdoğu
88 papers receiving 927 citations
Peers
Hakan Özdoğu
Lolie C. Yu United States
İdil Yenicesu Türkiye
Anna Paola Iori Italy
Prateek Bhatia India
Matthias Dürken Germany
Iou‐Jih Hung Taiwan
Renée V. Gardner United States
Kurt Leibundgut Switzerland
Ching-Tien Peng Taiwan
Josette Champagne Canada
Citations per year, relative to Hakan Özdoğu Hakan Özdoğu (= 1×)
peers
Lolie C. Yu
Countries citing papers authored by Hakan Özdoğu
Since
Specialization
Citations
This map shows the geographic impact of Hakan Özdoğu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hakan Özdoğu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hakan Özdoğu more than expected).
Fields of papers citing papers by Hakan Özdoğu
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hakan Özdoğu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hakan Özdoğu. The network helps show where Hakan Özdoğu may publish in the future.
Co-authorship network of co-authors of Hakan Özdoğu
This figure shows the co-authorship network connecting the top 25 collaborators of Hakan Özdoğu. A scholar is included among the top collaborators of Hakan Özdoğu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hakan Özdoğu. Hakan Özdoğu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Penack, Olaf, Christophe Peczynski, Nicolaus Kröger, et al.. (2025). GVHD prophylaxis in matched related stem cell transplantation: Why post-transplant cyclophosphamide can be recommended a study by the EBMT transplant complications working party. Leukemia. 39(6). 1503–1511.
2.
Fuente, Josu de la, Arnaud Dalissier, Mohsen Al Zahrani, et al.. (2024). Allogeneic Transplantation for Sickle Cell Disease Offers High Rates of Cure with Low Incidence of Severe Chronic GVHD in Both Children and Adults: Real World Data from 2010-2021. An Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party. Blood. 144(Supplement 1). 176–176.
3.
Sharma, Deva, İlknur Kozanoğlu, Kenneth I. Ataga, et al.. (2024). Managing sickle cell disease and related complications in pregnancy: results of an international Delphi panel. Blood Advances. 8(4). 1018–1029.
4.
Özdoğu, Hakan, et al.. (2024). Long-Term Outcomes of Allogeneic Stem Cell Transplantation for Relapsed/Refractory Hodgkin and Non-Hodgkin Lymphoma: Multi-center Experience from Turkey. Indian Journal of Hematology and Blood Transfusion. 41(1). 43–52.
5.
Labopin, Myriam, Sebastian Giebel, Thomas Schroeder, et al.. (2022). Total body irradiation plus fludarabine versus busulfan plus fludarabine as a myeloablative conditioning for adults with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. A study on behalf of the Acute Leukemia Working Party of the EBMT. Bone Marrow Transplantation. 58(3). 282–287.
6.
Kozanoğlu, İlknur, et al.. (2021). Is It Possible to be a Stem Cell Donor for the Second Time: A Single-Center Report of 12 Consecutive Procedures. Experimental and Clinical Transplantation.
7.
Yeral, Mahmut, Can Boğa, Ali Ünal, et al.. (2020). A Comparison of the BEAM and MITO/MEL Conditioning Regimens for Autologous Hematopoietic Stem Cell Transplantation in Hodgkin Lymphoma: An Analysis of Efficiency and Treatment-Related Toxicity. Clinical Lymphoma Myeloma & Leukemia. 20(10). 652–660.
8.
Dholaria, Bhagirathbhai, Myriam Labopin, Emanuele Angelucci, et al.. (2020). Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia. Transplantation and Cellular Therapy. 27(2). 171.e1–171.e8.
9.
Boğa, Can, Mahmut Yeral, Çiğdem Gereklioğlu, et al.. (2018). Effects of two doses of anti-T lymphocyte globulin-Fresenius given after full-match sibling stem cell transplantation in acute myeloblastic leukemia patients who underwent myeloablative fludarabine/busulfan conditioning. Hematology/Oncology and Stem Cell Therapy. 11(3). 149–157.
10.
Kozanoğlu, İlknur & Hakan Özdoğu. (2018). Use of red blood cell exchange for treating acute complications of sickle cell disease. Transfusion and Apheresis Science. 57(1). 23–26.
11.
Özdoğu, Hakan, Can Boğa, Süheyl Asma, et al.. (2018). Organ damage mitigation with the Baskent Sickle Cell Medical Care Development Program (BASCARE). Medicine. 97(6). e9844–e9844.
12.
Özdoğu, Hakan, Can Boğa, Mahmut Yeral, et al.. (2018). Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial. Bone Marrow Transplantation. 53(7). 880–890.
13.
Rubio, Marie Thérèse, Maud D’Aveni, Myriam Labopin, et al.. (2017). Impact of in vivo T cell depletion in HLA-identical allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission conditioned with a fludarabine iv-busulfan myeloablative regimen: a report from the EBMT Acute Leukemia Working Party. Journal of Hematology & Oncology. 10(1). 31–31.
14.
Kozanoğlu, İlknur, et al.. (2015). A Retrospective Study on Patients with Guillain-Barré Syndrome Treated with Therapeutic Plasma Exchange and Other Treatment Options A Centre’s Experience. European Neurological Review. 10(1). 81–81.
15.
Asma, Süheyl, et al.. (2014). Detection of vitamin B12 levels with the aid of some hematological and biochemical parameters that are more sensitive. DergiPark (Istanbul University).
16.
Adan, Aysun, Hakan Özdoğu, Can Boğa, et al.. (2014). Therapeutic Potential of Apigenin, a Plant Flavonoid, for Imatinib-Sensitive and Resistant Chronic Myeloid Leukemia Cells. Nutrition and Cancer. 66(4). 599–612.
17.
Özdoğu, Hakan, et al.. (2014). Cobalamin Deficiency Can Mask Depleted Body Iron Reserves. Indian Journal of Hematology and Blood Transfusion. 31(2). 255–258.
18.
Boğa, Can, et al.. (2010). Alterations of circulating endothelial cells after apheresis in patients with sickle cell disease: A potential clue for restoration of pathophysiology. Transfusion and Apheresis Science. 43(3). 273–279.
19.
Özdoğu, Hakan, et al.. (2007). Flow cytometric evaluation of circulating endothelial cells: A new protocol for identifying endothelial cells at several stages of differentiation. American Journal of Hematology. 82(8). 706–711.
20.
Yılmaz, Zerrin, et al.. (2005). Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients. Clinical and Experimental Medicine. 5(2). 55–59.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Lolie C. Yu Breakdown of academic impact, for papers by İdil Yenicesu Breakdown of academic impact, for papers by Anna Paola Iori Breakdown of academic impact, for papers by Prateek Bhatia Breakdown of academic impact, for papers by Matthias Dürken Breakdown of academic impact, for papers by Iou‐Jih Hung Breakdown of academic impact, for papers by Renée V. Gardner Breakdown of academic impact, for papers by Kurt Leibundgut Breakdown of academic impact, for papers by Ching-Tien Peng Breakdown of academic impact, for papers by Josette Champagne